Stockscreener 앱 받기
1.86
1.06%
-0.02
시간 외 거래:
1.91
0.05
+2.69%
전일 마감가:
$1.88
열려 있는:
$2.04
하루 거래량:
448.94K
Relative Volume:
4.71
시가총액:
$7.82M
수익:
$125.00K
순이익/손실:
$-14.64M
주가수익비율:
-0.3599
EPS:
-5.1674
순현금흐름:
$-15.06M
1주 성능:
-6.06%
1개월 성능:
-25.30%
6개월 성능:
-51.94%
1년 성능:
-87.38%
1일 변동 폭
$1.811
$2.08
1주일 범위
$1.811
$2.15
52주 변동 폭
$1.811
$13.43
Imunon Inc Stock (IMNN) Company Profile
명칭
Imunon Inc
전화
(609) 896-9100
주소
997 LENOX DRIVE, LAWRENCEVILLE
Compare IMNN vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IMNN
Imunon Inc
|
1.86 | 8.19M | 125.00K | -14.64M | -15.06M | -5.1674 |
VRTX
Vertex Pharmaceuticals Inc
|
458.99 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
607.93 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
892.26 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
282.72 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
157.77 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Imunon Inc 주식(IMNN)의 최신 뉴스
IMNN Q1 2026 Earnings: Narrowing Loss Beats Estimates as Clinical Progress ContinuesOne-Time Loss Impact - newsline.com
Imunon (IMNN) chair receives stock grant and updates IRA holdings - Stock Titan
Imunon (IMNN) CEO Stacy Lindborg granted 1,593 shares as salary stock - Stock Titan
IMNN Q1 2026 Earnings: Narrower-Than-Expected Loss Per Share as Company Advances PipelineDividend Increase Stocks - newsline.com
Imunon Secures $10 Million Funding Package to Advance Phase 3 Ovarian Cancer Study (IMNN) - MSN
Imunon Secures 10 Million Dollars Funding for Ovarian Cancer Trial - HarianBasis.co
Imunon Secures 10 Million Dollar Funding for Ovarian Cancer Trial - sekbernews.id
Imunon IMNN Q4 2025 Earnings Transcript - AOL.com
Imunon stock rises on $10M financing for cancer trial By Investing.com - Investing.com India
Imunon stock rises on $10M financing for cancer trial - Investing.com
IMUNON Secures Up to $10 Million Financing to Advance Phase 3 Ovarian Cancer Trial - citybiz
Imunon Secures $10 Million Non-Dilutive Structured Financing - TipRanks
Imunon Secures $10 Million Financing From Streeterville Capital; Issues Preferred Stock and Notes - TradingView
Imunon (Nasdaq: IMNN) secures $10M structured financing for Phase 3 OVATION 3 - Stock Titan
IMUNON Announces Up to $10 Million Cash Financing - GlobeNewswire
Imunon, Inc. announced that it has received $10 million in funding - marketscreener.com
IMNN Q1 2026 Earnings: Narrower Loss Per Share Surpasses Analyst ExpectationsEarnings Revision Upgrade - The Legal Advocate
Imunon Inc. (IMNN) Holds Steady Near Support as Traders Eye Breakout PotentialFactor ETF Flow - The Legal Advocate
Imunon Shares Trade Early After CEO Gets Stock Grant - Bez Kabli
IMNN Q1 2026 Earnings: Narrower-Than-Expected Loss as Clinical Progress ContinuesEPS Consistency Score - newsline.com
Imunon (IMNN) Executive Chairman awarded 3,484 shares in stock-based salary - Stock Titan
Imunon (IMNN) director granted 5,557 shares in lieu of board fees - Stock Titan
Imunon (IMNN) director receives 11,148-share stock grant in lieu of board fees - Stock Titan
Imunon (IMNN) director takes board fees in 5,011-share stock grant - Stock Titan
Imunon (IMNN) director granted 10,330 shares as board fee compensation - Stock Titan
Imunon (IMNN) CEO Stacy Lindborg receives 1,491-share stock grant in lieu of cash pay - Stock Titan
Imunon Inc. (IMNN) Holds Steady at $2.20 as Trading Activity Reflects ConsolidationEase of Movement - newsline.com
Imunon Inc. (IMNN) Nudges Higher Amid Tight Trading RangeCalendar Spread Trade - Newser
IMNN Q1 2026 Earnings: Narrower-than-expected loss drives small share gainUpward Estimate Revision - newsline.com
IMNN Stock Price, Quote & Chart | IMUNON INC (NASDAQ:IMNN) - ChartMill
Imunon (IMNN.US) is scheduled to release its earnings report before the market opens on March 31. - Moomoo
Imunon (IMNN) Up +0.71% — 3 Reasons the Rally Could Continue 2026-05-21Ichimoku TK Cross - Newser
Imunon Earnings Call Balances Breakthroughs and Cash Strain - TipRanks
Why Is Imunon, Inc. (CLSN) Stock Up Today? - Meyka
Imunon (IMNN) Flat at $2.25 — Consolidation Continues 2026-05-19Moving Average Crossovers - newsline.com
Why Is Imunon, Inc. (CLSN) Stock Down Today? - Meyka
Imunon (IMNN) Slides -3.61% as Selling Pressure Mounts 2026-05-18Skew Index - Newser
Earnings call transcript: Imunon Inc. misses Q1 2026 EPS forecast, stock dips - Investing.com
Imunon targets OVATION 3 last patient enrollment in Q1 2029 while outlining preferred-share financing options - MSN
Armistice Capital (IMNN) discloses 396,718 shares, 9.99% stake - Stock Titan
Q1 2026 Imunon Inc Earnings Call Transcript - GuruFocus
IMNN SEC FilingsImunon Inc 10-K, 10-Q, 8-K Forms - Stock Titan
IMNN: On Track to Have 80 Patients Enrolled in Phase 3 OVATION 3 Trial by 1Q27 - Yahoo Finance
UK Housing Market Gloom Persists, RICS Survey Signals Continued WeaknessSocial Trade Signals - newser.com
Imunon (IMNN) Declines -3.00% Amid Market Weakness 2026-05-13AI Signals - newser.com
Imunon | 10-Q: Q1 2026 Earnings Report - Moomoo
Imunon, Inc. (NASDAQ:IMNN) Q1 2026 Earnings Call Transcript - Insider Monkey
Imunon Q1 2026 Earnings Preview - MSN
Imunon Inc (IMNN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.60%
0.94%
자본화:
|
볼륨(24시간):